Advanced search
Publication Cover
Clinical and Experimental Hypertension. Part A: Theory and Practice Volume 9, 1987 - Issue 5-6
Journal homepage
5
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Presynaptic Dopamne Receptors in the Cardiovascular System

S. Z. Langer Department of Biology, Laboratolres d'Etudes et de Recherches Synthelabo, 58, rue de la Gladfere, 75013, Paris, France
,
M. Vidal Department of Biology, Laboratolres d'Etudes et de Recherches Synthelabo, 58, rue de la Gladfere, 75013, Paris, France
&
N. Duval Department of Biology, Laboratolres d'Etudes et de Recherches Synthelabo, 58, rue de la Gladfere, 75013, Paris, France
Pages 837-851 | Published online: 03 Jul 2009

References

  • Langer S. Z. Presynaptic receptors and their role in the regulation of transmitter release. Sixth Gaddum Memorial Lecture. Br. J. Pharmac. 1977; 60: 481–497
  • Langer S. Z. Presynaptic regulation of the release of catecholamines. Pharmacological Reviews 1981; 32: 337–362
  • Enero M. A., Langer S. Z. Inhibition by dopamine of 3Hnoradrenaline release elicited by nerve stimulation in the isolated cat's nictitating membrane. Naunyn Schmiedeberg's Arch. Pharmacol. 1975; 289: 179–203
  • Dubocovich M. L., Langer S. Z. Dopamine and α-adrenoceptor agonists inhibit neurotransmission in the cat spleen through different presynaptic receptors. J. Pharmacol. Exp. Ther. 1980; 212: 144–152
  • Langer S. Z., Dubocovich M. L. Physiological and pharmacological role of the regulation of noradrenaline release by presynaptic dopamine receptors in the peripheral nervous system. Peripheral dopaminergic receptors, J. L. Imbs, J. Schwartz. Pergamon Press. 1978; 233–246
  • Langer S. Z., Adler-Graschinsky E., Giorgi O. Physiological significance of α-adrenoceptor-mediated negative feed-back mechanism regulating noradrenaline release during nerve stimulation. Nature 1977; 265: 648–650
  • Langer S. Z., Armstrong J. M. Prejunctional receptors and the cardiovascular system : Pharmacological and therapeutic relevance. Cardiovascular Pharmacology, M. J. Antonaccio. Raven Press, New York 1984; 197–213
  • Cavero I., Lefevre-Borg F., Lhoste F., Sabatier C., Richer C., Giudicelli J. F. Pharmacological hemodynamic and autonomic nervous system mechanisms reponsible for the blood pressure and heart rate lowering effects of pergolide in rats. J. Pharmacol. Exp. Ther. 1985; 228: 779–791
  • Gessa G. L., Cuenca E., Costa E. On the mechanism of hypotensive effects of MAO inhibitors. Ann. N. Y. Acad. Sci. 1963; 107: 935–944
  • Puig M., Wakade A. R., Kirpekar S. M. Effect on the sympathetic nervous system of chronic treatment with pargyline and 1-dopa. J. Pharmacol. Exp. Ther. 1972; 182: 130–134
  • Petruzzo P., Arbilla S., Allen J., Langer S. Z. Electrical stimulation releases 3H-betaxolol from rat atrial slices : possible role of noradrenergic nerves. Naunyn Schmiedeberg's Arch. Pharmacol. 1986; 332: 253–257
  • Shepperson N. B., Duval N., Langer S. Z. Dopamine decreases mesenteric blood flow in the anaesthetized dog through the stimulation of postsynaptic α-adrenoceptors. Eur. J. Pharmacol. 1982; 81: 627–635
  • Shepperson N. B., Duval N., Massingham R., Langer S. Z. Differential blocking effects of several dopamine receptors antagonists for peripheral pre- and postsynaptic dopamine receptors in the anaesthetized dog. J. Pharmacol. Exp. Ther. 1982; 221: 753–761
  • Langer S. Z., Arbilla S. Pharmacological significance of pre- and postsynaptic dopamine receptors. Dopamine Receptor Agonists, G. Poste, S. T. Crooke. Plenum Press. 1984; 157–176
  • Tyce G. M., Sharpless N. S., Muenter M. D. Free and conjugated dopamine in plasma during levodopa therapy. Clin. Pharmac. Ther. 1974; 16: 782–788
  • Barbeau A. L-dopa therapy in Parkinson's disease : a critical review of nine year's experience. Canad. Med. Ass. J. 1969; 101: 791–800
  • Calne D. B., Brennan J., Spiers A. S. D., Stern G. M. Hypotension caused by 1-dopa. Brit. Med. J. 1970; 1: 474–475
  • Lokhandwala M. F., Buckley J. P. The effect of L-dopa on peripheral sympathetic nerve function : role of presynaptic dopamine receptors. J. Pharmac. Exp. Ther. 1978; 204: 362–370
  • Kopin I. J., Fisher J. E., Musacchio J. M., Horst W. D., Weise V. K. False neurochemical transmitters and the mechanism of sympathetic blockade by monoamine oxidase inhibitors. J. Pharmac. Exp. Ther. 1985; 147: 186–193
  • Soares da Silva P. A comparison between the pattern of dopamine and adrenaline release from sympathetic neurons of the drug mesenteric artery. Br. J. Pharmac. 1987; 90: 91–98
  • Fuder H., Muscholl E. The effect of dopamine on the overflow of endogenous noradrenaline from the perfused rabbit heart evoked by sympathetic nerve stimulation. Naunyn Schmiedeberg's Arch. Pharmacol. 1978; 305: 109–115
  • Langer S. Z. Presynaptic regulation of catecholamine release. Biochem. Pharmac. 1974; 26: 1793–1800
  • Lee M. R. Dopamine and the kidney. Clin. Sci. 1982; 62: 439–448

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.